Physician profile
Persida S Drotar
NPI 1902245053
$8,284.68
in general payments reported to CMS, 2019-2025
17 companies · $2,982 in 2025
The $2,982 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $50.18 · 2021: $389 · 2022: $765 · 2023: $1,743 · 2024: $1,225 · 2025: $2,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,251 · Travel and Lodging: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,251.25 |
| Travel and Lodging | $1,698.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,908.01 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $2,143.83 | 2019-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Atricure, INC. | $1,743.70 | 2021-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Abiomed | $406.57 | 2020-2024 | Impella |
| Shockwave Medical, INC | $173.22 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Heartflow, INC. | $127.28 | 2024 | |
| Janssen Pharmaceuticals, INC | $124.15 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $123.47 | 2023 | Tagrisso |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.95 | 2020-2023 | Lifevest |
| Kci USA, INC. | $106.30 | 2021 | |
| Davol INC. | $87.91 | 2019 | |
| Abbott Laboratories | $71.57 | 2024 | Navitor |
| Avanos Medical | $46.80 | 2019 | |
| Getinge USA Sales, LLC | $36.83 | 2024 | Cardiosave Hybrid, Type B Plug |
| Haemonetics Corporation | $36.25 | 2023 | Teg6s Hemostasis System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $17.17 | 2025 | Giapreza |
| Convatec INC. | $16.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Persida Drotar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.